Default company panoramic image
Logo

Leuko Ophthalmic Technologies Limited (LeukoTech)

Contact Lenses with active coloration, exhibiting bright colors when outside an eye and perfectly clear upon insertion into an eye.

  • Stage Prototype Ready
  • Industry Medical Devices and Equipment
  • Location Herzliyya, IL
  • Currency USD
  • Founded June 2009
  • Employees 4
  • Website leukotech.com

Company Summary

LeukoTech is developing a set of contact lens fabrication technologies for producing contact lenses with “active coloration” characteristics. Active Coloration, in a variety of colors and patterns will assist contact lens users with the daily chore of locating, inserting, and removing their left and right contact lenses. Active Coloration in specific patterns mitigates the likelihood of insertion of a “flipped” contact lens into the eye.

Team

  • Default avatar
    Alon Blankstein
    CEO

    Financial & BizDev exec with broad experience in all aspects of fundraising, marketing, business strategy and management. Vast Experience in managing and mentoring Life sciences ventures.

    I co founded, mamanged, invested & on the advisory board of several Israeli based technology ventures including LeukoTech, Partners500, Foamix, CapsuLINT and EarlySense to name a few

  • Default avatar
    Vladinir Sherman
    CTO & Co Founder & Patent Counsel

    a US-registered patent attorney and US attorney with over 18 years of experience in developing and commercializing patent portfolios. During his years or practice, Vladimir has worked with leading international companies, including IBM, L3-Communications, and Intel. Vladimir also has extensive experience working with leading Israeli companies including Saifun Semiconductors, RadVision, and Given Imaging.

  • Default avatar
    Jonathan Pasternak
    Co Founder

    is an award-winning filmmaker and Israeli artist. After Mr. Pasternak graduated from Bezalel Academy of Art and Design Jerusalem, his film "Live Life" won 3 international awards

  • Default avatar
    Nir Sinai
    VP R&D

    Mr. Sinai has an extensive engineering background with specialty in medical devices. In his previous position as Director of Engineering of Hanita Lenses, one of Israel largest contact lens companies. Prior to Hanita, Mr. Sinai worked at Navotek Medical, ConTIPI Ltd, and Euroka Ltd. Nir holds a B.Sc in Mechanical Engineering from the Technion and an MBA from University of Haifa.

  • Default avatar
    Shlomo Magdassi
    Advisory Board

    is a professor of applied chemistry, at the Casali Institute of Applied Chemistry and the center of Nanoscience at the Hebrew University of Jerusalem. In addition to basic scientific research he conducts industrial R&D projects, such as digital printing and conductive inks, cosmetics and pharmaceutics. He is the author of over a hundred scientific publications, and the editor of three books. He also has about 130 patents and patent applications.

  • Default avatar
    Barak Azmon
    Advisory Board

    Barak Azmon, MD - Co-founder and CEO of Notal Vision.
    Dr. Azmon formerly worked at the Ophthalmology Department of the Tel Aviv Sourasky Medical Center. Prior to founding Notal Vision, he founded and managed an educational company.

  • Default avatar
    Hanan Waksman
    Co Founder & CFO

    Vetran Investment Banker, Buy-side Investor CFO and Board Member. He is currently the CEO of Topspin Medical Inc. Previous positions include EVP at Capital International, and at Sage Capital Growth, Senior manager at the Corporate Finance Group of PWC Israel. Investment Banker with the M&A Group of JPMorgan in New York. and analyst at Ortec. Mr. Waksman holds a BBA in Finance from Baruch College

  • Default avatar
    Dr. Doron Friedman
    Advisory Board

    Dr. Friedman is the VP R&D of Lipocure and Co Founder of CapsuLINT & JPMED prior to that CTO and Co founder of Foamix to name a few. Doron Friedman holds a B.Pharm., M.Sci and PhD from the Hebrew University of Jerusalem School of Pharmacy in pharmaceutical sciences and a registered pharmacist.

    Doron expertise is in bio-pharmaceutics, Drug Delivery Systems, pharmaceutical formulation, drugs oral absorption and bio-availability. Doron record en

Previous Investors

  • Default avatar
    Vladimir Sherman
    Unconfirmed